AcroMeta Group Limited (SG:43F) has released an update.
AcroMeta Group Limited is actively working on securing additional funding and refinancing by completing the sale of Acromec Engineers, which has already brought in S$1.5 million, and planning the sale of its shares in Life Science Incubator Holdings for S$2.7 million. The latter transaction, deemed a ‘Major Transaction’ under Catalist Rules, requires shareholder approval and will see LSI cease to be a subsidiary of the Group. These strategic moves are part of the company’s efforts to address financial challenges and boost its cash flow position.
For further insights into SG:43F stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
